Navigation Links
Swiss, EMA, US Pharmacopoeia and World Health Organization Authorities to Provide an Update on Cool Chain Regulations

LONDON, January 23, 2012 /PRNewswire/ --

Representatives of Swiss, EMA, US Pharmacopoeia and WHO will discuss the new regulatory landscape as well as provide the feedback from recent inspections of pharmaceutical manufacturers at 11th Annual Cool Chain Logistics Europe, 30 January - 01 February 2012 in Basel, Switzerland.

Over 400 attendees including senior representatives from : Novo Nordisk, Genzyme, Pfizer, Abbott, Pliva, Amgen, Bayer, GlaxoSmithKline, Johnson & Johnson, Ipsen, Roche, Novartis, Sanofi, Alcon Couvreur, Agilent, Allergan, Baxter, Bacher, Celgene, Biotest, Synthes, Shire Pharmaceuticals and Forest Laboratories will meet to discuss issues such as regulatory GDP guidelines, distribution partnerships and ambient transportation solutions.

For more information on the event, visit, email: or call: +44-(0)207-368 9300

Press are invited to attend this important industry forum. If you would like to a press pass, please email Joanna Checinska on

Media contact:

Joanna Checinska


Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Waters and NIBRT Complete Work on Worlds First UPLC Glycan Database
2. LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
3. The worlds smallest magnetic data storage unit
4. Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
5. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
6. U of Toronto experiment named top breakthrough of 2011 by Physics World
7. West Palm Beach, FL to Host 8th Annual World Stem Cell Summit December 3-5, 2012
8. StemCyte Adds World Class Talent to its North America and Global Operations
9. The worlds smallest steam engine
10. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
11. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
Post Your Comments:
(Date:11/25/2015)... 2015 --> ... - 2020 report analyzes that automating biobanking workflow ... in long-term samples, minimizing manual errors, improving the ... manual errors such as mislabeling or inaccurate sample ... plays a vital role in blood fractionation, DNA ...
(Date:11/25/2015)... 25, 2015 2 nouvelles études permettent ... les différences entre les souches bactériennes retrouvées dans la ... des êtres humains . Ces recherches  ouvrent une nouvelle ... prise en charge efficace de l,un des problèmes ... chats .    --> 2 nouvelles études ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. 25, ... HART ), a biotechnology company developing bioengineered organ ... Jim McGorry will present at the LD Micro ... at 2:30 p.m. PT. The presentation will be webcast ... days. Management will also be available at the conference ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
Breaking Biology Technology:
(Date:10/26/2015)... 26, 2015 ... adds Biometrics Market Shares, Strategies ... well as Emerging Biometrics Technologies: Global ... its collection of IT and Telecommunications ... --> . ...
(Date:10/23/2015)... 23, 2015 Research and Markets ( ... Voice Recognition Biometrics Market 2015-2019" report to their ... The global voice recognition biometrics market to grow ... --> --> The report, ... based on an in-depth market analysis with inputs from ...
(Date:10/22/2015)...  Synaptics (NASDAQ: SYNA ), a leading developer of human ... September 30, 2015. --> --> ... 66 percent over the comparable quarter last year to $470.0 million. ... million, or $0.62 per diluted share. --> ... of fiscal 2016 grew 39 percent over the prior year period ...
Breaking Biology News(10 mins):